Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$35.61 - $76.23 $39,171 - $83,853
-1,100 Reduced 85.54%
186 $7,000
Q1 2022

Apr 29, 2022

BUY
$57.56 - $82.54 $56,984 - $81,714
990 Added 334.46%
1,286 $90,000
Q2 2021

Jul 15, 2021

SELL
$93.66 - $139.27 $45,893 - $68,242
-490 Reduced 62.34%
296 $37,000
Q2 2020

Jul 24, 2020

BUY
$55.75 - $92.75 $15,052 - $25,042
270 Added 52.33%
786 $68,000
Q1 2020

May 06, 2020

BUY
$37.9 - $104.44 $9,778 - $26,945
258 Added 100.0%
516 $30,000
Q1 2019

May 03, 2019

BUY
$61.98 - $96.5 $15,990 - $24,897
258 New
258 $22,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Focused Wealth Management, Inc Portfolio

Follow Focused Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.